FDA Approved: POTELIGEO — Original Application (Kyowa Kirin, Inc.)

View source ↗

Summary

The FDA approved Poteligeo (mogamulizumab-kpkc) in the original BLA for adults with relapsed or refractory mycosis fungoides or Sézary syndrome, a type of cutan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Poteligeo (mogamulizumab)

Snippet

ORIG AP for POTELIGEO (MOGAMULIZUMAB-KPKC)